PAPER
Synthesis of Stable b-Amino Alcohol N-Boranes
1061
IR (neat): 3273 (m, OH), 3115 (m, NH), 2936 (m), 2353 (s, BH),
2261 (s, BH), 1602 (s), 1299 (s), 1163 (s, N→B), 1044 (s), 699 (s),
747 (s) cm–1.
1H NMR (500 MHz, CDCl3): d = 7.37–7.15 (m, 5 H, phenyl), 4.22
(br s, 1 H, NH), 3.87 (dd, J1 = 11.5 Hz, J2 = 2.3 Hz, 2 H, OCH, NH),
3.57 (dd, J1 = 11.5 Hz, J2 = 5.3 Hz, 1 H, OCH), 3.04 (m, 1 H, CH2-
phenyl), 3.01 (s, 2 H, NCH, OH), 2.79 (m, 1 H, CH2-phenyl), 1.49
(br s, 3 H, BH3).
13C NMR (125 MHz, CDCl3): d = 136.5 (C-7), 129.4 (C-6, C-6¢),
129.1 (C-4), 127.3 (C-5, C-5¢), 60.7 (C-1), 59.5 (C-2), 35.6 (C-3).
HRMS (ESI): m/z calcd for C18H25N2O [(2M + H)+ – 2BH3 – H2O]:
285.1961; found 285.1969.
(2S)-(+)-2-Amino-4-methylsulfanylbutan-1-ol N-Borane (3e)
The reaction of (S)-methionine (2.24 g, 15.0 mmol) with NaBH4
(2.28 g, 60 mmol) following the above general procedure furnished
3e (1.45 g, 65%) as a colorless viscous oil.
[a]D20 +51.1 (c 1.4, EtOH).
IR (neat): 3225 (m, OH), 3142 (w, NH), 2915 (m), 2860 (w), 2316
(s, BH), 2273 (s, BH), 1585 (m), 1427 (m), 1163 (s, N→B), 1077
(s), 1039 (s), 997 (s) cm–1.
1H NMR (500 MHz, CDCl3): d = 4.36 and 4.20 (2 × s, 2 H, NH2),
3.89 (dd, J1 = 11.5 Hz, J2 = 4.9 Hz, 1 H, OCH2), 3.62 (dd, J1 = 11.5
Hz, J2 = 6.3 Hz, 1 H, OCH2), 2.99 (s, 1 H, OH), 2.97 (m, 1 H, NCH),
2.54 (m, 2 H, SCH2), 2.00 and 1.76 (2 × m, 2 H, CH2CH2S), 2.09 (s,
3 H, SCH3), 1.36 (br s, 3 H, BH3).
13C NMR (125 MHz, CDCl3): d = 61.6 (C-1), 57.9 (C-2), 30.9 (C-
3), 28.3 (C-4), 15.8 (C-5).
HRMS (ESI): m/z calcd for C5H14NOS [(M + H)+ – BH3]: 136.0791;
UV/Vis (CHCl3): lmax (e) = 220 (2032), 258 nm (208).
Anal. Calcd for C9H16BNO: C, 65.50; H, 9.77; N, 8.49. Found: C,
65.31; H, 9.47; N, 8.12.
(2S)-(+)-2-Amino-4-methylpentan-1-ol N-Borane (3c)
The reaction of (S)-leucine (1.96 g, 15.0 mmol) with NaBH4 (2.28
g, 60 mmol) following the above general procedure furnished 3c
(0.91 g, 46%) as a colorless viscous oil.
found 136.0795.
UV/Vis (CHCl3): lmax (e) = 227 (560), 260 nm (88).
Anal. Calcd for C5H16BNOS: C, 40.28; H, 10.81; N, 9.39. Found:
C, 40.40; H, 10.66; N, 9.24.
[a]D20 +45.4 (c 1.3, EtOH).
IR (neat): 3231 (m, OH), 3150 (w, NH), 2956 (s), 2871 (m), 2320
(s, BH), 2272 (s, BH), 1586 (m), 1467 (m), 1165 (s, N→B), 1039
(s), 756 (s) cm–1.
1H NMR (500 MHz, CDCl3): d = 4.24 (s, 1 H, NH2), 3.82 (dd,
J1 = 11.3 Hz, J2 = 3.8 Hz, 2 H, OCH2), 3.49 (m, 1 H, NCH), 3.23 (br
s, 1 H, OH), 2.79 (s, 1 H, NH2), 1.53 (m, 3 H, CH2CH), 1.25 (br s,
3 H, BH3), 0.84 [d, J = 5.6 Hz, 6 H, (CH3)2C].
13C NMR (125 MHz, CDCl3): d = 61.8 (C-1), 57.1 (C-2), 39.1 (C-
3), 25.1 (C-4), 23.2 (C-5), 22.6 (C-5¢).
HRMS (ESI): m/z calcd for C12H29N2O [(2M + H)+ – 2BH3 – H2O]:
(2S)-(+)-2-Amino-3-(1H-indol-2-yl)-propan-1-ol N-Borane (3f)
The reaction of (S)-tryptophan (3.1 g, 15.0 mmol) with NaBH4 (2.28
g, 60 mmol) following the above general procedure furnished 3f
(1.28 g, 42%) as a colorless viscous oil.
[a]D20 +25.2 (c 1.0, MeOH).
IR (neat): 3360 (s, OH), 3252 (s, NH), 3146 (m, NH), 2954 (w),
2332 (s, BH), 2307 (s, BH), 1596 (m), 1454 (m), 1162 (s, N→B),
1027 (s), 749 (s) cm–1.
1H NMR (500 MHz, CD3OD): d = 7.58 (d, J = 7.6 Hz, 1 H, ArH),
7.31 (d, J = 7.9 Hz, 1 H, ArH), 7.12–6.92 (m, 3 H, ArH), 4.58 (s, 4
H, NH, NH2, OH), 3.71 (dd, J1 = 10.7 Hz, J2 = 4.5 Hz, 1 H, OCH2),
3.48 (dd, J1 = 5.8 Hz, J2 = 14.2 Hz, 1 H, OCH2), 3.19 (dd, J1 = 14.2
Hz, J2 = 7.6 Hz, 1 H, OCH2), 2.96 (m, 1 H, NCH), 2.95 (m, 2 H,
CH2), 1.52 (br s, 3 H, BH3).
13C NMR (125 MHz, CD3OD): d = 137.2 (C-4), 127.8 (C-11),
123.6 (C-6), 121.6 (C-8), 118.9 (C-7), 118.5 (C-9), 111.4 (C-10),
110.3 (C-5), 61.2 (C-1), 59.5 (C-2), 24.9 (C-3).
HRMS (ESI): m/z calcd for C11H17N2O [(M + 3H)+ – BH3]:
193.1324; found 193.1330.
217.2274; found: 217.2284.
UV/Vis (CHCl3): lmax (e) = 226 (287), 258 nm (49).
Anal. Calcd for C6H18BNO: C, 55.00; H, 13.85; N, 10.69. Found C,
55.48; H, 14.00; N, 10.73.
(2S,3S)-(+)-2-Amino-3-methylpentan-1-ol N-Borane (3d)
The reaction of (S)-isoleucine (1.96 g, 15.0 mmol) with NaBH4
(2.28 g, 60 mmol) following the above general procedure furnished
3d (1.09 g, 56%) as a colorless viscous oil.
[a]D20 +29.4 (c 1.6, EtOH).
UV/Vis (MeOH): lmax (e) = 224 (26580), 280 nm (681).
IR (neat): 3238 (m, OH, NH), 2962 (s), 2933 (m), 2877 (w), 2318
(s, BH), 2272 (s, BH), 1586 (m), 1461 (m), 1163 (s, N→B), 1033
(s), 997 (s), 962 (m), 864 (w) cm–1.
Anal. Calcd for C11H17BN2O: C, 64.74; H, 8.40; N, 13.73. Found:
C, 64.53; H, 8.26; N, 13.58.
1H NMR (500 MHz, CDCl3): d = 4.32 and 3.70 (2 × s, 2 H, NH2),
3.90 (dd, J1 = 11.6 Hz, J2 = 3.4 Hz, 1 H, OCH2), 3.62 (dd, J1 = 11.6
Hz, J2 = 3.4 Hz, 1 H, OCH2), 2.84 (s, 1 H, OH), 2.67 (m, 1 H, NCH),
1.90 (m, 1 H, CH), 1.41 and 1.18 (2 × m, 2 H, CH2CH3), 1.63 (br s,
3 H, BH3), 0.91 (d, J = 7.3 Hz, 3 H, CH3CH), 0.86 (t, J = 7.3 Hz, 3
H, CH3CH2).
13C NMR (125 MHz, CDCl3): d = 62.7 (C-1), 59.6 (C-2), 34.1 (C-
3), 26.4 (C-4), 14.4 (C-6), 11.6 (C-5).
HRMS (ESI): m/z calcd for C12H29N2O [(2M + H)+ – 2BH3 – H2O]:
217.2274; found 217.2281.
Supporting Information for this article is available online at
Acknowledgment
We thank NCSR Demokritos and the National Technical University
of Athens for financial support. A.P. is grateful to the NCSR Demo-
kritos for a PhD fellowship. The Foundation for Education and Eu-
ropean Culture is also acknowledged for providing a scholarship to
G.C.V. Mrs. E. Yannakopoulou (Institute of Physical Chemistry,
NCSR Demokritos) and Dr. L. Leontiadis (Institute of Radioiso-
topes & Radiodiagnostic Products, NCSR Demokritos) are grateful-
ly acknowledged for carrying out elemental analysis measurements
and for obtaining the HRMS spectra, respectively.
UV/Vis (CHCl3): lmax (e) = 226 (280), 252 nm (54).
Anal. Calcd for C6H18BNO: C, 55.00; H, 13.85; N, 10.69. Found: C,
55.16; H, 14.20; N, 10.36.
© Thieme Stuttgart · New York
Synthesis 2012, 44, 1057–1062